Irene Quan

For rich and developing countries alike, it is imperative to confront issues of drug safety, quality, and manufacturing to ensure an equitable distribution of essential medicines to the populations who need them most.

The re-energized advent of telemedicine has opened doors to additional opportunities that will not only reduce exposure to COVID-19 and mitigate strains on hospital systems, but also expand access to healthcare and improve overall health outcomes for years to come.